Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FDM00
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,128
Award facts
- Contract value 100% obligated
- $30,127.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on September 18, 2025, for the supply of EXPAREL 266 mg/20 mL vials. EXPAREL is a liposomal bupivacaine formulation used for infiltration and nerve block anesthesia in surgical procedures. This firm fixed-price delivery order has a ceiling value of $30,127.56 and is scheduled for completion by October 9, 2025. The order will be fulfilled from the vendor's location in Park Ridge, Illinois. No set-aside designation was used for this award.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a significant vehicle valued at approximately $500 million through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities. DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler that has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its registered status in the System for Award Management since 2001 to compete effectively in federal procurement markets without set-aside designations.
Quick answers
Who was awarded contract SPE2DB25FDM00?
SPE2DB25FDM00 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FDM00 worth?
The government has obligated $30,128 on SPE2DB25FDM00.
Is contract SPE2DB25FDM00 an order under another contract?
Yes. SPE2DB25FDM00 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDM00 competed?
The extent of competition for SPE2DB25FDM00 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award